Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: Primary results from the randomized, double-blind, phase III FUTURE 5 study
Mease P et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212687
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.